Subject: MJNA Sub HempMeds® Sponsors International Medical Cannabis Expo in Colombia

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MJNA Sub HempMeds® Sponsors International Medical Cannabis Expo in Colombia
Hot Stock to WatchHot Stock to Watch

Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)


Price: 0.098

Change (%): + 0.0011 (1.14)

Volume: 2,210,839
MJNA Chart

Medical Marijuana, Inc. Subsidiary HempMeds® Sponsors International Medical Cannabis Expo in Colombia

SAN DIEGO, Nov. 28, 2017 /PRNewswire/ - Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the U.S., announced today that subsidiary HempMeds® was a Gold Sponsor of EXPO MEDE Weed, the second International Fair of Medical Cannabis, which took place in Medellín, Colombia on November 24-27, 2017.

This conference is organized annually to discuss the legality of medical cannabis globally. Currently in Colombia, non-psychotropic Cannabis (Hemp) is legal to grow if it contains less than 1% THC.

At the conference, executives from the Medical Marijuana, Inc. portfolio of companies spoke to hundreds of patients and doctors at the event about CBD and shared stories of previous international successes in Mexico, Brazil and Paraguay. Speakers included Dr. Stuart Titus, CEO of Medical Marijuana, Inc., and Raul Elizalde, President of HempMeds® Mexico.

“We are proud to sponsor this global event and speak with an international audience about our products and the benefits of CBD,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are working to bring HempMeds® to Colombia in 2018.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks